Gyre Therapeutics Inc. (GYRE)
GYRE trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$6.71
-2.26% on the day
Market cap
$748.2M
Small cap
Revenue · 2025
$116.6M
+10.2% on 2024
Net income · 2025
$9.9M
8.5% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | GYRE on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2006 |
| SEC CIK | 0001124105 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $116.6M |
| Net income | $9.9M |
| Operating income | $11.5M |
| Net margin | 8.5% |
| Operating margin | 9.9% |
| Revenue growth | +10.2% |
| Cash | $49.2M |
| Total assets | $219.8M |
| P/E (computed) | 75.7× |
| P/S (computed) | 6.4× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2026-06-23 |
| Latest annual report | 10-K | 2026-03-13 |
| Latest quarterly / interim | 10-Q | 2026-08-07 |
| Latest current report | 8-K | 2026-09-01 |
| Latest proxy | DEFA14A | 2026-05-04 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -7.7% |
| 1 month | -2.9% |
| 3 months | +1.2% |
| Year to date | -8.0% |
| 1 year | -22.6% |
| From 52-week high | -26.8% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| APMD | Apnimed Inc. | $17.83 | -4.29% | $742.3M |
| OBX | Obsidian Therapeutics Inc. | $11.99 | -6.25% | $740.7M |
| ANL | Adlai Nortye Group Ltd. | $11.76 | -17.34% | $757.0M |
| HELP | Helus Pharma Inc. | $10.50 | -4.80% | $767.1M |
| GERN | Geron Corporation | $1.20 | -1.64% | $771.0M |
| ANNX | Annexon Inc. | $3.83 | -3.28% | $726.1M |
| IMMX | Immix Biopharma Inc. | $8.69 | -6.05% | $720.4M |
| ARDX | Ardelyx Inc. | $3.12 | -3.41% | $777.5M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier